Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.
about
Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells.The capacity of target silencing by Drosophila PIWI and piRNAs.A distinct first replication cycle of DNA introduced in mammalian cells.Site-specific integrase-mediated transgenesis in mice via pronuclear injectionHerpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type compositionHuman gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing.Nonviral ocular gene therapy: assessment and future directions.Progress and prospects: the design and production of plasmid vectors.Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.Analysis of human embryonic stem cells with regulatable expression of the cell adhesion molecule l1 in regeneration after spinal cord injury.RNAi-mediated knockdown of mouse melanocortin-4 receptor in vitro and in vivo, using an siRNA expression construct based on the mir-187 precursor.Nanoparticles for retinal gene therapy.Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.Towards effective non-viral gene delivery vector.Transient recombinant protein expression in a human amniocyte cell line: the CAP-T® cell system.Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.Herpes Virus Amplicon Vectors.Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression.Herpes simplex virus type 1/adeno-associated virus hybrid vectors.Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
P2860
Q33284257-F189E57C-2E83-4653-9E06-618DBD0062F4Q33713413-537809CB-5A57-4574-9DC5-4F156E4C85B4Q34273071-302A0862-4B6B-41F7-8BFD-49D95EF57CB6Q34547229-31B7CFC3-4956-4132-A3C1-8D49D3269201Q34723884-92AD763B-3E9C-4921-BC51-7817FAB7E81AQ34977843-8CE21B17-1E92-49FB-81FB-DD226A5F3509Q35280041-DF86EB53-79F6-44CD-B44D-7EA9D0F9F1EFQ36740271-81E0F9CC-E62D-4146-9776-11FB4F471910Q36897379-4DB77CE6-CB09-406F-A290-E3D40D4107E2Q36983992-7AFC03C0-6F57-44F6-A503-066A6A7E883BQ37150852-47B5AF28-3D52-4CBF-ADDC-88C4CFE31B1DQ37284890-FB1A6F8A-F0F3-468B-A1F3-A9222FC002C1Q37364447-B429D401-5D45-4295-B1F7-C1BC416463AAQ37445505-5445B6B1-B612-4E6B-94E0-E9919C0295E6Q37528088-D285BA5A-1536-413E-9770-5CD7EE660A43Q37629973-6AAE0D11-2A2B-441E-9A9B-2D9C96880DF8Q37634693-5D86A9DC-C02B-4875-AC08-C2E27245E9FEQ37746102-164D6E64-081E-4BB0-B432-5CDA67178258Q37784704-7AF4E0AB-E1D4-400D-BBB6-6D3EAE3B946FQ37895283-DA11AB97-65CD-485F-A343-96F65773129FQ38830057-CE6B32B0-A545-4879-93A5-A2B3AD2034EBQ39367320-7813FE4A-8863-41C0-BB2F-5AF47B514179Q39473687-281C0B39-BF35-426E-88A6-0685F38E417BQ39576163-3EE62E98-A23B-472F-B22E-C1604FF44467Q39595240-D48B04DC-0ECB-4CFF-A2A9-7F508398B000Q39601616-83E36A95-6FBA-452C-956B-8632DE63D926Q39923388-F8BBB2AE-B1A7-449A-858B-CFDE7808C48EQ40033809-5997AEB5-C9DB-4E6F-99BE-82518FED884BQ42002320-6479E0A6-550C-4AFD-A2FE-4C48C3D0E158Q42448457-B070A2C8-C5E9-4A44-B676-8D600AB1BF7FQ58779571-6C55030F-5D4A-4296-87B7-E3C5F6171735
P2860
Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Plasmid DNA sequences present ...... by forming inactive chromatin.
@en
type
label
Plasmid DNA sequences present ...... by forming inactive chromatin.
@en
prefLabel
Plasmid DNA sequences present ...... by forming inactive chromatin.
@en
P2093
P2860
P1433
P1476
Plasmid DNA sequences present ...... by forming inactive chromatin.
@en
P2093
Kazue Kasai
Masataka Suzuki
Yoshinaga Saeki
P2860
P304
P356
10.1128/JVI.80.7.3293-3300.2006
P407
P577
2006-04-01T00:00:00Z